Carasent published its interim report for Q2 2026
Net sales rose 18% to SEK 97.7 million, with an EBITDA margin of 15% and adjusted EBITDA margin of 19%.
See the latest news and media coverage for Carasent. We track all announcements, press releases, and industry mentions in real time, all in one place.
Health tech group providing digital healthcare solutions
carasent.comLast updated
In short: Carasent achieved 18% revenue growth in Q2 2026, reaching SEK 97.7 million, and finalized the acquisition of Swedish firm Infosolutions.
Net sales rose 18% to SEK 97.7 million, with an EBITDA margin of 15% and adjusted EBITDA margin of 19%.
The interim report publishes July 10 at 07:00, followed by a webcast at 08:00 CET. Registration links provided.
Purchase price SEK 128 million, partly paid in cash and shares.
The acquisition values Infosolutions at SEK 115 million and strengthens Carasent's position in Swedish private healthcare. Completion is expected in Q2 2026.
Carasent AB (publ) (FRA:E0C) reports robust recurring revenue and strategic acquisitions, while addressing profitability and market expansion challenges.
The IT company Carasent had net sales of SEK 97.7 million (82.9) in the second quarter of 2026, a net sales growth of 18 percent.
Carasent (publ) Registered is expected to present the financial report for the quarter ended 30.06.2026 on 10.07.2026.3 analysts...
Visit a quote page and your recently viewed tickers will be displayed here.
Track Carasent and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Carasent and other trending companies.